
Burgeoning Hybrid Atrial Fibrillation Program at THI Bolstered by FDA Approval of Innovative New EPi-Sense Treatment System
Dr. Jennifer Cozart Now Seeks to Further Expand THI’s Cutting-Edge Atrial Fibrillation Minimally Invasive Hybrid Treatment for Patients Suffering from...